|
MRI News Service:
Contrast Agents p25 |
|
|
|
 |
 | | | 'Nephrogenic systemic fibrosis (NSF), described in 2000 (1), is an emerging systemic disorder characterized by widespread tissue fibrosis. Originally known as nephrogenic fibrosing dermopathy because of its dominant cutaneous findings, the nomenclature ...' | | Thursday, 1 March 2007 by radiology.rsna.org |
|
|
|
| | | 'Nanoscale magnets in the form of iron-containing molecules might be used to improve the contrast between healthy and diseased tissue in magnetic resonance imaging (MRI)?as long as the concentration of nanomagnets is carefully managed?according to a new ...' | | | Thursday, 1 February 2007 by www.eurekalert.org | |
|
|
|
| | | 'Tiny particles one-billionth of a meter in size can be loaded with high concentrations of drugs designed to kill brain cancer. What's more, these nanoparticles can be used to image and track tumors as well as destroy them, according to researchers at ...' | | | Wednesday, 15 November 2006 by www.sciencedaily.com | |
|
|
|
| | | 'SUNNYVALE, Calif., Nov 09, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced the presentation of preliminary results of an open-label multi-center Phase 2 clinical trial, which suggest that ...' | | | Thursday, 9 November 2006 by ir.pharmacyclics.com | |
|
|
|
| | | 'The purpose of this study was to assess oral contrast agents, volumes of the agents, and time points of data acquisition in regard to small-bowel distention and patient acceptance. outine cross-sectional imaging procedures require delineation of the ...' | | | Sunday, 1 October 2006 by www.ajronline.org | |
|
|
|
| | | 'Researchers at New York University have made chemical modifications to nanometer sized virus particles--a process that has the potential to improve magnetic resonance imaging (MRI) techniques. Their results are reported in the latest issue of Nano ...' | | | Tuesday, 13 June 2006 by www.eurekalert.org | |
|
|
|
| | | 'Research by scientists based at the University of Illinois at Urbana-Champaign may lead to the development of a new breed of "multimodal" contrast agents that could work within a host of medical imaging platforms -- from ultrasound and computed ...' | | | Wednesday, 7 June 2006 by www.eurekalert.org | |
|
|
|
| | | 'The drug Xcytrin®, based on a molecule developed by chemists at The University of Texas at Austin, shows significant promise in prolonging cognitive function in patients with non-small cell lung cancer that has metastasized to the ...' | | | Monday, 5 June 2006 by www.sciencedaily.com | |
|
|
|
| | | 'CAMBRIDGE, Mass.-A new technique devised by MIT engineers may one day help physicians detect cancerous tumors during early stages of growth.
The technique allows nanoparticles to group together inside cancerous tumors, creating masses with enough of a ...' | | | Tuesday, 2 May 2006 by www.sciencedaily.com | |
|
|
|
| | | 'Tokyo, Apr 26, 2006 (JCN) - Meiji Dairies and Kyowa Hakko Kogyo have obtained approval for BOTHDEL Oral Solution, an oral MRI contrast medium for the gastrointestinal tract, from the Ministry of Health, Labor and Welfare.
The new product, which can ...' | | | Wednesday, 26 April 2006 by www.japancorp.net | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
A common mistake that people make when trying to design something completely
foolproof is to underestimate the ingenuity of complete fools.
- Douglas Adams |
|
|
News
top
